Share This Page
Drug Price Trends for CHLOROQUINE PH
✉ Email this page to a colleague
Average Pharmacy Cost for CHLOROQUINE PH
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CHLOROQUINE PH 250 MG TABLET | 64980-0177-50 | 2.69649 | EACH | 2025-06-18 |
| CHLOROQUINE PH 500 MG TABLET | 23155-0850-74 | 5.45926 | EACH | 2025-06-18 |
| CHLOROQUINE PH 500 MG TABLET | 62135-0717-26 | 5.45926 | EACH | 2025-06-18 |
| CHLOROQUINE PH 500 MG TABLET | 00115-7010-09 | 5.45926 | EACH | 2025-06-18 |
| CHLOROQUINE PH 500 MG TABLET | 64980-0178-02 | 5.45926 | EACH | 2025-06-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Chloroquine Phosphate Market Analysis and Price Projections
Market Overview
The chloroquine phosphate market is a significant segment within the pharmaceutical industry, driven primarily by its essential role in treating malaria, autoimmune diseases, and other health conditions. Here’s a comprehensive analysis of the market, including its current state, drivers, and future projections.
Market Size and Growth
As of 2023, the global chloroquine phosphate market was valued at approximately USD 850 million. It is projected to grow at a Compound Annual Growth Rate (CAGR) of around 3% from 2024 to 2031, reaching a market value of USD 1045.39 million by 2031[2][5].
Key Drivers
Malaria Treatment
Malaria remains a significant public health concern, particularly in developing countries. The ongoing need for efficient therapies in endemic areas continues to drive the demand for chloroquine phosphate. Africa, where malaria is most prevalent, dominates the market, accounting for the largest share[5].
Autoimmune Diseases
Chloroquine phosphate is also used in the treatment of autoimmune diseases such as lupus and rheumatoid arthritis. The increasing prevalence of these conditions further propels market growth[2][3].
Research and Development
Continuous research into the potential applications of chloroquine phosphate, including its use in treating viral infections and other therapeutic areas, expands business opportunities and drives market expansion[2][5].
Public Health Initiatives
Global efforts to prevent infectious diseases and public health campaigns enhance the availability and usage of chloroquine phosphate, contributing to market growth[2].
Market Segmentation
By Application
The market is segmented by application, with malaria treatment being the dominant segment. Other significant applications include lupus treatment, rheumatoid arthritis treatment, COVID-19 research, and veterinary medicine[2][5].
By Product Type
The market is also segmented by product type, including pharmaceutical grade, analytical grade, reagent grade, industrial grade, and technical grade[2].
By Region
Geographically, the market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Africa leads the market due to the high prevalence of malaria, while the Asia-Pacific region is expected to witness the fastest growth during the forecast period[1][5].
Competitive Landscape
The chloroquine phosphate market is characterized by the presence of several major players, including:
- Bayer
- Rising Pharmaceutical
- Sun Pharma
- Shanghai Pharma
- Sichuan Sunny Hope
- Guangzhou Baiyunshan Guanghua Pharmaceutical
- CSPC Group
- KPC Group
- Jinghua Pharmaceutical Group
- Zhongsheng Pharma
- North China Pharmaceutical Group[1].
These companies are actively engaged in the production, distribution, and supply of chloroquine phosphate, catering to the global demand.
Market Trends and Challenges
Increasing Demand
The global population's aging and increased susceptibility to infections are likely to heighten the demand for antimalarial drugs like chloroquine phosphate[3].
Drug Resistance
However, the increasing prevalence of drug resistance and the shift towards alternative antimalarial treatments, such as artemisinin-based combination therapies, may limit the long-term reliance on chloroquine phosphate in the management of malaria[5].
Research and Development
Ongoing research into novel therapeutic applications and the enhancement of medication formulations are expected to continue driving market growth[2][5].
Price Projections
Given the projected growth rate of 3% CAGR from 2024 to 2031, the market value is expected to increase steadily. Here are some key price projections:
- 2023: USD 850 million
- 2031: USD 1045.39 million[2].
Regional Price Variations
Prices can vary significantly by region due to differences in demand, regulatory environments, and distribution costs. For instance, in regions with high malaria prevalence, such as sub-Saharan Africa, the price may be influenced by public health programs and subsidies[5].
Future Outlook
The future outlook for the chloroquine phosphate market is cautiously optimistic. Here are some key points:
- Continued Growth: The market is expected to continue growing due to the ongoing burden of malaria and the potential exploration of chloroquine phosphate for other therapeutic applications[5].
- Challenges: The increasing prevalence of drug resistance and the shift towards alternative treatments may pose challenges to the long-term growth of the market[5].
"Despite significant progress in malaria control and elimination efforts, the disease continues to affect millions of people globally, with the majority of cases and deaths occurring in sub-Saharan Africa."[5]
Key Takeaways
- The global chloroquine phosphate market is valued at USD 850 million as of 2023 and is projected to reach USD 1045.39 million by 2031.
- The market is driven by the need for malaria treatment, autoimmune disease management, and ongoing research into new therapeutic applications.
- Africa dominates the market due to the high prevalence of malaria.
- The Asia-Pacific region is expected to witness the fastest growth during the forecast period.
- Major players include large pharmaceutical companies and specialized manufacturers of antimalarial drugs.
- The market faces challenges from drug resistance and the adoption of alternative treatments.
FAQs
Q: What is the current market size of the chloroquine phosphate market?
A: The global chloroquine phosphate market was valued at approximately USD 850 million in 2023[2].
Q: What is the projected growth rate of the chloroquine phosphate market?
A: The market is expected to grow at a CAGR of around 3% from 2024 to 2031[2][5].
Q: Which region dominates the chloroquine phosphate market?
A: Africa dominates the market due to the high prevalence of malaria in the region[5].
Q: What are the main applications of chloroquine phosphate?
A: The main applications include malaria treatment, lupus treatment, rheumatoid arthritis treatment, COVID-19 research, and veterinary medicine[2][5].
Q: Who are the major players in the chloroquine phosphate market?
A: Major players include Bayer, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, and several other large pharmaceutical companies and specialized manufacturers[1].
Sources
- OpenPR: Chloroquine Phosphate Tablets (COVID-19) Market Development Strategy Report 2024: Expanding Reach and Impact.
- Market Research Intellect: Chloroquine Phosphate Market Size and Projections.
- Verified Market Research: Hydroxychloroquine And Chloroquine Market Valuation – 2024-2031.
- Market Research Reports: Global Chloroquine Phosphate Market Insights, Forecast to 2030.
- Data Horizzon Research: Chloroquine Phosphate Market Size, Share & Forecast 2033.
More… ↓
